2014
9 December

More work needed on new EMA conflicts of interest policy
18 September

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry
23 June

Setting precedents: EMA must get clinical trial data policy right to truly act in public interest
11 June

HAI Europe calls on EMA's Management Board to stand for data transparency
11 June

BMJ statins debate about scientific independence, not rigour
20 May

World Health Assembly 67: HAI intervention on the WHO's framework of engagement with non-state actors
12 February

Enhancing accountability in the medicines market: The Medicines Transparency Alliance
23 January

Regulation critical to clinical trials data transparency in Europe
2013
9 August

True clinical trials transparency? Not quite, EFPIA.
2011
20 May

Statement on conflicts of interest delivered at WHA on behalf of HAI, Berne Declaration, KEI, TWN, PHM, IBFAN
17 May

Conflicts of Interest and the Future of Financing for WHO.
29 April

Foundations: Conlicts of interests and Democracy issues
25 February

European drug regulator challenged over revolving door case involving former Director
1 February

Corporate funding linked to EU patient & consumer groups policy
2010
20 December

EMA reviews transparency criteria
1 December

HAI research on financial disclosure featured in article: European politicians' call for greater transparency
25 October

ACTA, Democracy & Access to Medicines
22 October

HAI Europe Statement: EMA talks the ‘conflicts of interest’ talk, but will it walk the walk?
23 September

Dutch Minister of Health supports HAI E's financial transparency recommendations to EMA
30 August

In perspective: EMA comments on HAI Europe's survey of financial disclosure
25 August

Impact of HAI Europe survey results: Two weeks on
11 August

HAI Europe survey reveals new data on financial transparency of patient and consumer organisations
28 June

HAI Europe recommendations for improved conflict of interest declarations at EMA
23 June

ISDB & MiEF criticize EMA over conflict of interest procedures
14 June

Review of conflict of interest policies in three European medicines regulation agencies
11 May

EU Ombudsman: Transparency rules apply to all documents held by EMA
10 May

Patient groups not only for sick people's interests – says Portuguese sociologist
6 May

Citizens call for inquiry into EU response to H1N1 outbreak
28 April

European Medicines Agency faces tough questions about patient groups' transparency
26 April

Patient Groups need dose of transparency